Skip to main content
Fig. 6 | Acta Neuropathologica Communications

Fig. 6

From: Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis

Fig. 6

Effect of surfen on proteoglycan mRNA expression during EAE. a Expression of HSPGs as indicated. b Expression of CSPGs as indicated. Data compare CFA + PTX controls treated with vehicle (CFA-V) or surfen (CFA-S) to EAE treated with vehicle (EAE-V) or surfen (EAE-S). Significance is shown as mean ± SEM; significant data are marked, comparing vehicle treated EAE with CFA-vehicle (# = P < 0.05) or between groups as indicated by cross bars (* = P < 0.05)

Back to article page
\